Alpha-synuclein impairs triglyceride metabolism and mitochondrial structure in aging nematodes
Restoring lipid balance through medium-chain triglycerides or fatty acid inhibition protected worms from alpha-synuclein-driven movement deficits.
EMBO reports · Zhang T et al. · Paper published 29 Sep 2026
In the nematode Caenorhabditis elegans, researchers found that alpha-synuclein progressively alters lipid metabolism during aging. The protein reduces total triacylglycerols and disrupts the structures of both lipid droplets and mitochondria. These structural defects depend on the ability of alpha-synuclein to bind lipids and condense into inclusions. While reducing triacylglycerols, alpha-synuclein also proportionally increases long-chain unsaturated fatty acids. Modifying these lipid pathways countered the damage in worms. Genetically blocking the synthesis of long-chain unsaturated fatty acids alleviated alpha-synuclein-induced loss of motility. Supplementing the nematodes with medium-chain triglycerides also improved toxicity phenotypes. Noting that Parkinson's disease cohorts show lower plasma triacylglycerols, the researchers conclude that alpha-synuclein condensation impairs lipid balance to drive cellular toxicity.
Why it matters
The findings link protein aggregation directly to lipid depletion and mitochondrial damage in aging organisms. Understanding this metabolic disruption highlights medium-chain triglyceride supplementation as a potential therapeutic approach for age-related synucleinopathies.
Caveats
Most mechanistic findings rely on the invertebrate Caenorhabditis elegans, meaning the results may not fully translate to human neurobiology. The study also does not establish whether dietary medium-chain triglycerides are effective in human clinical trials.
Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.
The paper
Condensate-driven triglyceride reduction links α-synuclein to mitochondrial dysfunction
Zhang T, Herron-Bedoya A, Eugenia Goya M et al.
EMBO reports · 29 Sep 2026 · Peer-reviewed
- Relevance
- Relevant
- News value
- Notable
- Evidence
- Model organisms
- Status
- Peer-reviewed
More on Brain aging
See allHuman neurons accumulate far more mutations over lifespan than shorter-lived mammals
Cortical neurons gain mutations at similar yearly rates across six species, leaving aged humans with uniquely high mutational burdens and transcriptomic dysregulation.
bioRxiv : the preprint server for biology · Caglayan E et al.
CAR T cells targeting inflammatory bone marrow progenitors restore cognition in aged mice
Clearing these peripheral myeloid cells remodeled brain macrophages and improved cognitive performance without requiring the engineered immune cells to enter the brain.
bioRxiv · Harris AS et al.
Extracellular cGAMP drives neuroinflammation and premature aging phenotypes in mice
Loss of the cGAMP-degrading enzyme ENPP1 allows microglia-derived signaling molecules to trigger STING-dependent inflammation across multiple brain cell types.
bioRxiv · R. Carvalho D et al.
Directly converted human neuronal spheroids preserve donor age and model Alzheimer disease
The three-dimensional cell platform maintains biological aging markers while spontaneously developing hallmark pathologies of sporadic Alzheimer disease.
bioRxiv · Alsolami S et al.
Auditory nerve myelin degeneration defines a subtype of age-related hearing loss
Researchers linked poor auditory nerve synchrony and myelin degradation to amplified communication difficulties in older humans, beyond standard hearing thresholds.
medRxiv : the preprint server for health sciences · Harris KC et al.